中国实用外科杂志

中国实用外科杂志 ›› 2023, Vol. 43 ›› Issue (02): 231-234.DOI: 10.19538/j.cjps.issn1005-2208.2023.02.21

• 文献综述 • 上一篇    下一篇

低风险甲状腺微小乳头状癌的诊治进展

刘晓楠1，邸    旭1，张    强2，张文超2，王旭东2   

  1. 1 天津市第四中心医院乳腺甲状腺外科，天津 300140；2 天津医科大学肿瘤医院颌面耳鼻喉肿瘤科   国家肿瘤临床医学研究中心   天津市肿瘤防治重点实验室   天津市恶性肿瘤临床医学研究中心，天津 300060
  • 出版日期:2023-02-01 发布日期:2023-02-20

  • Online:2023-02-01 Published:2023-02-20

摘要： 无淋巴结转移和远处转移，无甲状腺腺体外侵犯，非病理高危亚型，无气管或喉返神经侵犯的甲状腺微小乳头状癌临床基本可以判定为低风险甲状腺微小乳头状癌。目前临床采取的治疗方式包括积极监测、手术以及消融治疗。但低风险甲状腺微小乳头状癌的诊断、治疗决策的制定仍然需要分子检测的发展以及综合考量肿瘤特征，病人以及医疗团队等多方面因素。

关键词: 甲状腺微小乳头状癌, 低风险, 积极监测, 消融治疗, 手术

Abstract: Advances in the diagnosis and treatment of low-risk papillary thyroid microcarcinoma        LIU Xiao-nan*, DI Xu，ZHANG Qiang, et al.*Department of Thyroid and Breast Oncology，Tianjin 4th Center Hospital，Tianjin 300140，China 
Corresponding author：WANG Xu-dong，E-mail：wxd.1133@163.com
Abstract    Papillary thyroid microcarcinoma with no lymph node metastasis or distant metastasis, no extra-thyroid invasion, non-pathologically high-risk subtypes, and no trachea or recurrent laryngeal nerve invasion could be clinically determined as low-risk papillary thyroid microcarcinoma.  The current clinical treatment methods include active surveillance, surgery and ablative therapy.  However, the diagnosis and treatment decisions of low-risk papillary thyroid microcarcinoma still need the development of molecular detection and the comprehensive consideration of tumor characteristics, patients and medical teams.  

Key words: papillary thyroid microcarcinoma, low risk, active surveillance, ablation therapy, surgery